Literature DB >> 22873802

Validity of cost and utility results?

Alex Diamantopoulos, Laura Sawyer, Sarika Ogale, Fred Dejonckheere.   

Abstract

Mesh：

Substances：

Year:  2012        PMID： 22873802     DOI： 10.2165/11633700-000000000-00000

Source DB:  PubMed          Journal:  Pharmacoeconomics        ISSN： 1170-7690            Impact factor:   4.981


× No keyword cloud information.
  1 in total

Review 1.  Cost utility of tumour necrosis factor-α inhibitors for rheumatoid arthritis: an application of Bayesian methods for evidence synthesis in a Markov model.

Authors:  Christine M Nguyen; Mark Bounthavong; Margaret A S Mendes; Melissa L D Christopher; Josephine N Tran; Rashid Kazerooni; Anthony P Morreale
Journal:  Pharmacoeconomics       Date:  2012-07-01       Impact factor: 4.981
  1 in total
  1 in total

1.  Decision-making analysis for allergen immunotherapy versus nasal steroids in the treatment of nasal steroid-responsive allergic rhinitis.

Authors:  Joshua L Kennedy; Derek Robinson; Jared Christophel; Larry Borish; Spencer Payne
Journal:  Am J Rhinol Allergy       Date:  2014 Jan-Feb       Impact factor: 2.467
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.